IL10 and lung disorder: LNs offer advantages such as high stability, large drug loading capacity, and non-toxicity (82), and although some LN-based platforms have been developed to enable targeted delivery to the lung (83–86), no studies have yet explored their use in IL-10 delivery or pulmonary disease treatment.